A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

759

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

November 28, 2017

Study Completion Date

November 28, 2017

Conditions
Acne Vulgaris
Interventions
DRUG

Olumacostat Glasaretil Gel, 5.0%

Gel containing Olumacostat Glasaretil

OTHER

Olumacostat Glasaretil Gel, Vehicle

Vehicle (placebo) gel

Trial Locations (49)

2217

St George Dermatology and Skin Cancer Centre, Kogarah

2606

Woden Dermatology, Phillip

3053

Skin & Cancer Foundation Inc., Carlton

5073

North Eastern Health Specialists, Hectorville

6160

Fremantle Dermatology, Fremantle

10022

Schweiger Dermatology, PLLC, New York

11790

DermResearchCenter of New York, Inc., Stony Brook

20850

Lawrence Jeffrey Green MD, LLC, Rockville

23507

Virginia Clinical Research, Inc., Norfolk

32771

International Clinical Research-US, LLC, Sanford

33126

Finlay Medical Research, Miami

33172

Lenus Research & Medical Group, Sweetwater

33401

Research Institute of the Southeast, LLC, West Palm Beach

34952

Health Awareness, Inc, Port Saint Lucie

37130

International Clinical Research - Tennessee LLC, Murfreesboro

International Clinical Research-Tennesse LLC, Murfreesboro

40217

Skin Sciences, PLLC, Louisville

46032

Forefront Dermatology, Carmel

48706

Great Lakes Research Group, Inc, Bay City

55432

Minnesota Clinical Study Center, Fridley

57049

Meridian Clincial Research, Dakota Dunes

60005

Arlington Dermatology, Arlington Heights

63090

Mercy Research, Washington

66215

Kansas City Dermatology, PA, Overland Park

68114

Quality Clinical Research Inc, Omaha

68134

Meridian Clinical Research, Omaha

68701

Meridian Clinical Research, LLC, Norfolk

75094

Synexus US, LP, dba, Research Across America, Murphy

77845

J &S Studies, Inc, College Station

78213

Progressive Clinical Research, PA, San Antonio

78229

Clinical Trials of Texas, Inc., San Antonio

Dermatology Clinical Research Center of San Antonio, San Antonio

78759

DermResearch, Austin

80220

Horizons Clinical Research Center, LLC, Denver

85032

Alliance Dermatology & MOHS Center, Phoenix

90045

Dermatology Research Associates, Los Angeles

92123

Rady Children's Hospital UCSD Pediatric and Adolescent Derm, San Diego

University Clinical Trials Inc., San Diego

92801

Anaheim Clinical Trials, Anaheim

97030

Cyn3rgy Research, Gresham

06484

Dermatology Physicians of CT, Shelton

07960

Acne Treatment & Research Center, Morristown

02919

Clinical Partners, LLC, Johnston

T3A 2N1

Institute for Skin Advancement, Calgary

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

L3P 1X2

Lynderm Research Inc., Markham

P1B 3Z7

North Bay Dermatology Centre, North Bay

M4W 2N2

Research Toronto, Toronto

N8W 5L7

Windsor Research Inc., Windsor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dermira, Inc.

INDUSTRY

NCT03028363 - A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris | Biotech Hunter | Biotech Hunter